STAT Plus: Pharmalittle: Pelosi plan rests with Dems who get big pharma bucks; Novartis recalls heartburn meds from U.S.
Rise and shine, everyone, another busy day is on the way. We can tell because the short person dashed to the local schoolhouse and our official mascot is entranced by squirrels and chipmunks, rather than napping in the corner. As for us, this means we have time to fire up the coffee kettle for a cup of stimulation — cinnamon dolce is our choice today for those who track this sort of indulgence — and scrounge about for items of interest. Speaking of which, here are some tidbits. Hope your day goes well and you conquer the world …
The fate of Nancy Pelosi’s drug pricing bill rests in the hands of lawmakers who received more campaign contributions from the pharmaceutical industry than almost all other Democrats, STAT says. Rep. Richard Neal (D-Mass.), who chairs the House Ways and Means Committee, received $111,500 in contributions from industry political action committees in the 2018 election cycle, the fifth-most of any lawmaker. Rep. Frank Pallone (D-N.J.), chairman of the House Energy and Commerce Committee, received $98,500, good for ninth-most.
